Today's Date: April 26, 2024
Manulife Investment Management Announces Forest Climate Fund's Second Close Bringing Total Commitments Up to $334.5 Million   •   Coastal Carolina, Southwestern Law School, and Other Institutions Streamline Accessibility Workflows With YuJa's PDF Remediation   •   United Imaging Healthcare releases 2023 annual report, with revenue growth of 23.52%   •   Nonprofits from Inception Fertility and Caden Lane Team Up to Expand Financial Accessibility to Fertility Care   •   The Sallie Mae Fund Grants $75,000 to DC College Access Program to Support Higher Education Access and Completion   •   Disneyland Resort Celebrates Return of Pixar Fest for a Limited Time, April 26-Aug. 4, 2024   •   United Imaging Healthcare Releases 2023 ESG Report, Advancing Mission of Equal Healthcare for All™   •   Emmy-winning Cyberchase Expands Digital Presence to Engage Every Kid, Everywhere Ahead of Season 15 Premiere   •   In Support of PEPSI® x Mary J. Blige Strength of a Woman Partnership, The Brand Launches $100,000 Fund to Support Yonkers Wo   •   Dual Enrollment Helps High School Students Launch Rewarding Careers   •   Carbon Removal and Mariculture Legislation Moves Forward in California Assembly   •   LENNAR NOW SELLING THREE NEW-HOME COLLECTIONS AT JUNIPERS, SAN DIEGO'S RESORT-STYLE COMMUNITY FOR ACTIVE ADULTS AGED 55 AND BETT   •   Suzano 2023 annual report on Form 20-F   •   McCain Foods Plants 18,000 Trees in Wisconsin, Fulfilling 2022 Promise to Plover Community   •   29 London Partners With US Media Company Bobi Media to Strengthen Market Offering   •   Kinaxis Positioned Highest on Ability to Execute in the Gartner® Magic Quadrant™ for Supply Chain Planning Solutions   •   Chase Opens Innovative Branch in Bronx’s Grand Concourse Neighborhood   •   BeiGene Demonstrates Global Progress in 2023 Responsible Business & Sustainability Report   •   C2N Diagnostics Expands Into Japan Through Mediford Corporation Partnership With Precivity™ Blood Testing for Alzheimer&rs   •   Operation HOPE and SBA Forge Strategic Alliance to Empower Small Businesses Across America
Bookmark and Share

New Study Gets to the Root of Fixing Pediatric Flatfeet

New Study Gets to the Root of Fixing Pediatric Flatfeet

PR Newswire

MACOMB, Mich., Feb. 25, 2020 /PRNewswire/ -- GraMedica is pleased to announce that the research team of Dr. Philip J. Bresnahan and Dr. Mario A. Juanto have published a new study this month focused on the misinformation surrounding the treatment of a common deformity known as pediatric flatfeet.

Pediatric flatfeet are caused by the partial dislocation of the ankle bone on the heel bone.

Historically, many medical professionals have not considered this condition abnormal and have advised patients that a child with a flatfoot would outgrow this condition. Dr. Bresnahan and Dr. Juanto's study shows that, left untreated, pediatric flatfeet persist into adulthood and are a leading cause of secondary deformities within the feet, knee, hips, and back.

The study further shows that typical treatments fail to fix the main issue; the partial dislocation of the ankle bone. Extra-Osseous Talotarsal Stabilization, or EOTTS, is proven to fix the problem at its root. This is a minimally invasive solution where a small spacer is placed into a naturally occurring space between the ankle and heel bones. The EOTTS procedure instantly, and internally, fixes the root cause of flatfeet.

"A big misconception is that flat-misaligned feet in children is normal and that they will auto-correct over time," shared Dr. Bresnahan, the lead researcher on the study. "This study shows that this is clearly not the case, plus there is an effective way to treat it and prevent further damage."

The study shows conclusively that there is no evidence of auto-correction of pediatric flatfeet, and that this deformity should not be ignored. EOTTS is proven to fix the problem at its root. The sooner this effective and minimally invasive surgical option is prescribed, the less damage will occur to other parts of the body, as well as one's physical and mental health.

About GraMedica

GraMedica is a global orthopedic company that specializes in the development of innovative foot and ankle solutions such as HyProCure®, Opti-Toe® and Osteo-wedge®. Our uniquely designed products provide surgeons with treatment options that create improved patient outcomes.

Together, with a dedicated group of renowned surgeons in over 70 countries, we have improved the quality of life for tens of thousands of patients. Our goal is to continue to educate, support and become an indispensable partner to foot and ankle surgeons, so we may continue changing the lives of patients worldwide, one step at a time.

For more information, visit www.gramedica.com or www.AlignMyFeet.com.

Media Contact:

Sofiya Dyachun

Email: sdyachun@gramedica.com

Related Links

GraMedica

AlignMyFeet

Cision View original content:http://www.prnewswire.com/news-releases/new-study-gets-to-the-root-of-fixing-pediatric-flatfeet-301009794.html

SOURCE GraMedica



Back to top
| Back to home page
Video

White House Live Stream
LIVE VIDEO EVERY SATURDAY
alsharpton Rev. Al Sharpton
9 to 11 am EST
jjackson Rev. Jesse Jackson
10 to noon CST


Video

LIVE BROADCASTS
Sounds Make the News ®
WAOK-Urban
Atlanta - WAOK-Urban
KPFA-Progressive
Berkley / San Francisco - KPFA-Progressive
WVON-Urban
Chicago - WVON-Urban
KJLH - Urban
Los Angeles - KJLH - Urban
WKDM-Mandarin Chinese
New York - WKDM-Mandarin Chinese
WADO-Spanish
New York - WADO-Spanish
WBAI - Progressive
New York - WBAI - Progressive
WOL-Urban
Washington - WOL-Urban

Listen to United Natiosns News